297 related articles for article (PubMed ID: 26456520)
1. CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice.
Wu X; Guo J; Ding R; Lv B; Bi L
Acta Histochem; 2015 Oct; 117(8):732-7. PubMed ID: 26456520
[TBL] [Abstract][Full Text] [Related]
2. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
Yao L; Chen HP; Ma Q
Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse.
Sato S; Zhang XK; Matsuoka N; Sumichika Y; Saito K; Yoshida S; Matsumoto H; Temmoku J; Fujita Y; Asano T; Migita K
Lupus Sci Med; 2023 Apr; 10(1):. PubMed ID: 37094946
[TBL] [Abstract][Full Text] [Related]
4. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice.
Huang MW; Stock AD; Putterman C
Front Immunol; 2021; 12():763065. PubMed ID: 34868008
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
Zhang Z; Liu D; Zhang X; Wang X
Inflammation; 2018 Oct; 41(5):1888-1899. PubMed ID: 29951872
[TBL] [Abstract][Full Text] [Related]
6. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
[TBL] [Abstract][Full Text] [Related]
7. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
10. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
Chen K; Deng Y; Shang S; Tang L; Li Q; Bai X; Chen X
Biomed Pharmacother; 2022 Sep; 153():113433. PubMed ID: 36076550
[TBL] [Abstract][Full Text] [Related]
11. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.
Moreth K; Brodbeck R; Babelova A; Gretz N; Spieker T; Zeng-Brouwers J; Pfeilschifter J; Young MF; Schaefer RM; Schaefer L
J Clin Invest; 2010 Dec; 120(12):4251-72. PubMed ID: 21084753
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic effect of total glucosides of paeony on lupus nephritis in MRL/lpr mice].
Ding ZX; Yang SF; Wu QF; Lu Y; Chen YY; Nie XL; Jie HY; Qi JM; Wang FS
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):656-60. PubMed ID: 21515463
[TBL] [Abstract][Full Text] [Related]
13. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
14. Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.
Hu Q; Yang C; Wang Q; Zeng H; Qin W
PLoS One; 2015; 10(7):e0133724. PubMed ID: 26208003
[TBL] [Abstract][Full Text] [Related]
15. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
Front Immunol; 2021; 12():584414. PubMed ID: 33717066
[TBL] [Abstract][Full Text] [Related]
17. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
He J; Sun M; Tian S
Innate Immun; 2018 Jul; 24(5):307-315. PubMed ID: 29874961
[TBL] [Abstract][Full Text] [Related]
18. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B; Ye H; You X; Ni H; Chen X; Li L
Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
[TBL] [Abstract][Full Text] [Related]
19. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
Li X; Liu J; Zhao Y; Xu N; Lv E; Ci C; Li X
BMC Nephrol; 2022 Jul; 23(1):243. PubMed ID: 35804318
[TBL] [Abstract][Full Text] [Related]
20. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
Ezzat M; El-Gammasy T; Shaheen K; Shokr E
Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]